MAPK1 and breast cancer: Furthermore, treatment with a synthetic RGD ligand targeting integrin β1 in PM2.5-exposed BC cells significantly reduced the expression of key signaling proteins in the MAPK/ERK pathway, thereby decreased both migration and β-catenin nuclear translocation.